Stockreport

Caldera Therapeutics Launches with $112.5 Million and Announces First Subjects Dosed in Phase 1 Trial of First-In-Class Bispecific Antibody CLD-423 for Inflammatory Bowel Disease [Yahoo! F...

Janus Henderson Group plc Ordinary Shares  (JHG) 
Last janus henderson group plc ordinary shares earnings: 4/30 04:00 am Check Earnings Report
US:NYSE Investor Relations: snl.com/irw/corporateprofile/4147331
PDF led by Omega Funds, with participation from additional new investors Wellington Management and Janus Henderson Investors Proceeds will fund ongoing clinical developmen [Read more]